8/20/2024Merck Adjusts ADC Partnership with Kelun-Biotech, Takes Up One Option ...

8/20/2024Adcendo Enters $1B Biobuck Deal for Multitude's Anti-TF ADC

8/20/2024TYK Medicines Raises $74M thru IPO to Fund Core Asset Development

8/20/2024U.S. Lawmakers Call on the FDA to Investigate Clinical Trials Conducte...

8/20/2024AstraZeneca Gains Chinese Approval of New Asthma Drug

8/20/2024Taking Stock of U.S.-China Biotechnology Competition (Asia Society)

8/19/2024Astellas Secures Chinese Approval of Nectin-4 ADC Drug

8/19/2024NMPA Restores Import, Sales and Use of UCB's Keppra

8/19/2024Germany Warns of Potential Drug Shortages Due to China's Espionage Law

8/19/2024Aurobindo to Begin Production in China Soon

8/19/2024FDA Lifts Partial Hold on BioNTech-MediLink ADC Study

8/16/2024Huadong Secures Asia Rights to Two South Korean Autoimmune Disease Dru...

8/16/2024DualityBio Initiates Phase 1 Trial of ADC drug DB-1419 for Various Sol...

8/16/2024Recent Official and Executive Moves

8/15/2024Akeso's sNDA for Ivonescimab (PD-1/VEGF) Granted Priority Review in Ch...

8/15/2024SAMR Releases Draft Pharma Anti-monopoly Guidelines

8/15/2024China Introduces Guidelines to Encourage Development of 'Digital, Smar...

8/15/2024Patent Term Compensation: New Policy Interpretation And Operation Guid...

8/14/2024China Biopharma Tracker – July 2024 (PharmaDJ)

8/14/2024Apollomics Announces Positive Preliminary Data of Vebreltinib

8/14/2024GSK Launches Phase 3 Trial for RSV Vaccine in China

8/13/2024OcuMension Acquires China Rights to Alcon Eye Drops with 16.7% Equity ...

8/13/2024MNC Pharma Companies in China Return to Growth after Years of VBP Turb...

8/13/2024Junshi's sNDA for Toripalimab as First-Line Treatment of Unresectable/...

8/13/2024AstraZeneca and Daiichi Sankyo Secure Third Approval For Enhertu in Ch...

8/12/2024Genor License ex-China Rights for CD20/CD3 Bispecific to TRC 2004

8/9/2024Sable Thera Announces Worldwide Licensing Deal with Columbia Univers...

8/9/2024Merck to Acquire Investigational B-Cell Depletion Therapy from Curon

8/9/2024Cullinan Returns Bispecific to Harbour BioMed One Year After Paying $2...

8/9/2024WuXi, Medigene Team Up for T Cell-activating Cancer Therapies

Page:68/789 Total number of articles:23668: [First][<<] [66] [67] [68] [69] [70] [>>] [End]